CYTK
CYTK
NASDAQ · Biotechnology

Cytokinetics Inc

$80.73
-0.47 (-0.58%)
Analyst Consensus
Strong Buy
28
Analysts
High
Coverage
Buy 24 86%
Hold 4 14%
Sell 0 0%
Price Target
Analyst Price Target -1.1% upside
Low Target $53.35
Average Target $79.81
High Target $115.71
Current Price $80.73
Current
$80.73
Target
$79.81
$53.35 $79.81 avg $115.71
Scenario Analysis
Bear Case
$53.35
-33.9%
Low target
Base Case
$79.81
-1.1%
Avg target
Bull Case
$115.71
+43.3%
High target
Risk/Reward
1.3x
Balanced
Price in Context
52-Week High
$80.20
0.7% from high
52-Week Low
$31.99
+152.4% from low
50-Day SMA
$63.59
+27.0% vs SMA
200-Day SMA
$49.97
+61.6% vs SMA
RSI (14)
55.5
Neutral
Target vs 52W High
$79.81
-0.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +5.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -46.4%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +191.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -9.5%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -36.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -45.5%